Alzheimer Disease Clinical Trials in Beijing
7 recruitingBeijing, China
Showing 1–7 of 7 trials
Recruiting
Phase 3
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
DementiaBrain DiseasesCentral Nervous System Diseases+6 more
Eli Lilly and Company1,500 enrolled141 locationsNCT05508789
Recruiting
Early Phase 1
Investigator Initiated Trial of Galcanezumab Treatment in Alzheimer's Disease
Alzheimer Disease
Xuanwu Hospital, Beijing10 enrolled1 locationNCT07323927
Recruiting
Phase 3
Clinical Analgesic Management in Dementia
Alzheimer Disease
Xuanwu Hospital, Beijing10 enrolled1 locationNCT07323914
Recruiting
Early Phase 1
Near-Infrared Light Therapy Combined With Lecanemab for Mild Alzheimer's Disease
Alzheimer Disease
Xuanwu Hospital, Beijing20 enrolled1 locationNCT06992804
Recruiting
Not Applicable
Effects and Mechanisms of Temporal Interference Brain Stimulation on Memory Function in Preclinical Alzheimer's Disease
Alzheimer Disease
Xuanwu Hospital, Beijing1,200 enrolled2 locationsNCT07031687
Recruiting
Phase 1
Study Safety and Efficacy of Deep Brain Stimulation (DBS) and Cervical Deep Lymphoid-venous Anastomosis (LVA) in Alzheimer's Disease
Alzheimer Disease
Chinese PLA General Hospital98 enrolled1 locationNCT07094438
Recruiting
Not Applicable
Alzheimer's Disease Treated With Vagus Nerve Stimulation
Alzheimer Disease (AD)
Beijing Municipal Administration of Hospitals74 enrolled1 locationNCT06923007